Fidelity Investments’s Anterix ATEX Stock Holding History
Bought
Maintained
Sold
Other funds holding ATEX
OCAM
HCL
VCM
QF
PM
GI
Fidelity Investments's ATEX Position: Q1 2026 in Review
Fidelity Investments increased its Anterix (ATEX) stake by 165% in Q1 2026, buying an estimated $2.67M and bringing the position to 135,295 shares worth $5.17M. The position accounts for ﹤0.01% of the portfolio, ranked #2294.
Fidelity Investments first reported a position in ATEX in Q1 2021 and has held it in 21 quarters since. The position peaked at $10.8M in Q1 2025. 132 funds tracked by Wall St. Rank hold ATEX as of Q1 2026.
- Fidelity Investments held 135,295 shares of Anterix worth $5.17M as of Q1 2026.
- Fidelity Investments bought 84,251 Anterix shares in Q1 2026, an estimated $2.67M.
- Anterix made up ﹤0.01% of Fidelity Investments's portfolio in Q1 2026, its #2294 holding.
- Fidelity Investments first reported a position in Anterix in Q1 2021 and has held it in 21 quarters since.
- Fidelity Investments's Anterix position peaked at $10.8M in Q1 2025.
- 132 funds tracked by Wall St. Rank held Anterix as of Q1 2026.
Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.